CA2005502A1 - Analogues de la somatotrophine - Google Patents

Analogues de la somatotrophine

Info

Publication number
CA2005502A1
CA2005502A1 CA 2005502 CA2005502A CA2005502A1 CA 2005502 A1 CA2005502 A1 CA 2005502A1 CA 2005502 CA2005502 CA 2005502 CA 2005502 A CA2005502 A CA 2005502A CA 2005502 A1 CA2005502 A1 CA 2005502A1
Authority
CA
Canada
Prior art keywords
analogs
somatotropin
somatotropin analogs
lactation
serine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2005502
Other languages
English (en)
Other versions
CA2005502C (fr
Inventor
Alan J. Parcells
John E. Mott
Che-Shen C. Tomich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CA2005502A1 publication Critical patent/CA2005502A1/fr
Application granted granted Critical
Publication of CA2005502C publication Critical patent/CA2005502C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
CA 2005502 1989-01-31 1989-12-15 Analogues de la somatotrophine Expired - Fee Related CA2005502C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30473389A 1989-01-31 1989-01-31
US07/304,733 1989-01-31

Publications (2)

Publication Number Publication Date
CA2005502A1 true CA2005502A1 (fr) 1990-07-31
CA2005502C CA2005502C (fr) 2001-06-05

Family

ID=23177749

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2005502 Expired - Fee Related CA2005502C (fr) 1989-01-31 1989-12-15 Analogues de la somatotrophine

Country Status (6)

Country Link
EP (1) EP0456642A1 (fr)
JP (1) JP3207416B2 (fr)
AU (1) AU620673B2 (fr)
CA (1) CA2005502C (fr)
DK (1) DK140491A (fr)
WO (1) WO1990008823A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0355460B1 (fr) * 1988-08-24 2000-12-27 American Cyanamid Company Stabilisation de somatotropines par modification du résidu cystéine en utilisant un site de mutagénèse dirigée ou par modification chimique
US5688666A (en) * 1988-10-28 1997-11-18 Genentech, Inc. Growth hormone variants with altered binding properties
US5534617A (en) * 1988-10-28 1996-07-09 Genentech, Inc. Human growth hormone variants having greater affinity for human growth hormone receptor at site 1
US5849694A (en) * 1990-07-16 1998-12-15 Synenki; Richard M. Stable and bioactive modified porcine somatotropin and pharmaceutical compositions thereof
DK0851925T3 (da) * 1995-09-21 2005-11-28 Genentech Inc Humane Væksthormonvarianter
US8008252B2 (en) 2001-10-10 2011-08-30 Novo Nordisk A/S Factor VII: remodeling and glycoconjugation of Factor VII
US7696163B2 (en) 2001-10-10 2010-04-13 Novo Nordisk A/S Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7795210B2 (en) 2001-10-10 2010-09-14 Novo Nordisk A/S Protein remodeling methods and proteins/peptides produced by the methods
NZ542094A (en) 2003-03-14 2008-12-24 Neose Technologies Inc Branched polymer conjugates comprising a peptide and water-soluble polymer chains
PL1615945T3 (pl) 2003-04-09 2012-03-30 Ratiopharm Gmbh Sposoby glikopegylacji i białka/peptydy wytwarzane tymi sposobami
JP2007523630A (ja) * 2003-05-09 2007-08-23 ネオス テクノロジーズ インコーポレイテッド ヒト成長ホルモングリコシル化突然変異体の組成と調合法
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US7842661B2 (en) 2003-11-24 2010-11-30 Novo Nordisk A/S Glycopegylated erythropoietin formulations
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US7956032B2 (en) 2003-12-03 2011-06-07 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
NZ548123A (en) 2004-01-08 2010-05-28 Novo Nordisk As O-linked glycosylation of peptides
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
WO2006031811A2 (fr) 2004-09-10 2006-03-23 Neose Technologies, Inc. Interferon alpha glycopegyle
WO2006050247A2 (fr) 2004-10-29 2006-05-11 Neose Technologies, Inc. Remodelage et glycopegylation du facteur de croissance des fibroblastes (fgf)
US9029331B2 (en) 2005-01-10 2015-05-12 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
WO2006121569A2 (fr) 2005-04-08 2006-11-16 Neose Technologies, Inc. Compositions et methodes utilisees pour la preparation de mutants par glycosylation de l'hormone de croissance humaine resistant a la protease
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (fr) 2005-11-03 2007-05-18 Neose Technologies, Inc. Purification de sucre de nucleotide en utilisant des membranes
EP2049144B8 (fr) 2006-07-21 2015-02-18 ratiopharm GmbH Glycosylation de peptides par l'intermédiaire de séquences de glycosylation à liaison o
EP2054521A4 (fr) 2006-10-03 2012-12-19 Novo Nordisk As Méthodes de purification de conjugués de polypeptides
HRP20130382T1 (hr) 2007-04-03 2013-05-31 Biogenerix Ag Postupci lijeäśenja pomoä†u glikopegiliranog g-csf
CA2690611C (fr) 2007-06-12 2015-12-08 Novo Nordisk A/S Procede ameliore pour la production de sucres de nucleotide
US8207112B2 (en) 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
PL2257311T3 (pl) 2008-02-27 2014-09-30 Novo Nordisk As Koniugaty cząsteczek czynnika VIII

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56026B1 (en) * 1982-10-19 1991-03-27 Cetus Corp Cysteine-depleted muteins of biologically active proteins

Also Published As

Publication number Publication date
AU4663189A (en) 1990-08-24
JP3207416B2 (ja) 2001-09-10
DK140491D0 (da) 1991-07-29
DK140491A (da) 1991-07-29
AU620673B2 (en) 1992-02-20
CA2005502C (fr) 2001-06-05
EP0456642A1 (fr) 1991-11-21
WO1990008823A1 (fr) 1990-08-09
JPH04503001A (ja) 1992-06-04

Similar Documents

Publication Publication Date Title
CA2005502A1 (fr) Analogues de la somatotrophine
CA2085750A1 (fr) Formulations pharmaceutiques favorisant l'osteogenese
GB8718777D0 (en) Variants of bovine pancreatic trypsin inhibitor
AUPP051497A0 (en) Antimicrobial peptides
DE69529219D1 (en) Helicobacter proteine und impstoffe
EP1225225A3 (fr) Dispositifs ostéogéniques
NZ227788A (en) Peptide having growth hormone regulatory effects, and compositions
NZ503850A (en) April - a novel protein with growth effects
FI91160B (fi) Menetelmä modifioidun ihmisen t-PA-proteiinin valmistamiseksi
HUT68021A (en) Improved activating process of recombinant proteins
GB9606040D0 (en) Active peptide
DE3572303D1 (en) Biologically active substances obtained from bovine casein, process for their preparation and compositions containing them
EP0161007A3 (fr) Analogues de l'hexapeptide rétro-inverso C-terminal de la substance P
IE902388L (en) Vasoactive intestinal peptide analogs.
CS335390A3 (en) Nonionic contrast means and process for preparing thereof
IL95863A0 (en) Anticoagulant peptides and compositions containing them
EP0384731A3 (fr) Facteurs de croissance ostéogéniques identifiés à partir de moelle osseuse régénératrice
GB8906156D0 (en) Production and use of anthelmintic agents and protective immunogens
HU896448D0 (en) Process for the preparation of anticoagulant peptides
ATE113986T1 (de) Verfahren zur herstellung von aprotinin und aprotinin-homologen in hefe.
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
IL95697A0 (en) Cdna sequence for porcine lactoferrin protein
GB2207132B (en) 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines
ATE202363T1 (de) Antibiotische peptide aus der kuhmilch
ZA876072B (en) Protein protease inhibitors from streptomyces

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed